NVDA's P/E drops to 24 on AI chip revenue hopes; still a buy for risk-tolerant investors.

ETH's 2.9% staking yield offers growth. Down 51% from ATH, it avoids hype tax, but SOL competes.

Bayer's Roundup liability hangs on SCOTUS. A win could cap ~$7.25B settlement exposure.

Atlassian's stock plunged 87%, but AI integration & strong retention signal recovery. P/S under 3 is a buy.

Lock in 4.05% APY on 9-month CDs! Jumbo CDs may offer higher yields, but check risks vs. returns.

GENI drops 60% YTD, but its pick-and-shovel model & acquisition could boost EPS to $0.60 by 2028.

Buffett's 11 words signal Berkshire's value investing stays, with $350B+ cash. Returns historically huge.